Evidence map›Paper›PMID 38739717›Full record

ArticleBlood advances2024

Bringing global hematology research to the forefront.

Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge Cortes

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrés Gómez-De LeónDepartment of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.ORCID 0000-0001-6904-9345
Andrés Noyola-PérezDepartment of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.ORCID 0000-0003-2713-2663
Lourdes Gil-FloresDepartment of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.ORCID 0000-0001-9884-097X
Hemant MalhotraDepartment of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India.
Vasile MusteataN. Testemitanu State University of Medicine and Pharmacy, Discipline of Hematology, Institute of Oncology, Department of Hematology, Chisinau, Republic of Moldova.ORCID 0000-0002-9471-7170
Amal El-BeshlawyCairo University, Cairo, Egypt.ORCID 0000-0003-3293-1806
Hilman TadjoedinDepartment of Internal Medicine, Dharmais National Cancer Center, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.ORCID 0009-0002-1844-8404
Carolina PavlovskyDepartment of Hematology and Research, Fundación de Lucha Contra la Leucemia, Buenos Aires, Argentina.
Jorge CortesDivision of Hematology/Oncology, Department of Medicine, Georgia Cancer Center at Augusta University, Augusta, GA.ORCID 0000-0002-8636-1071

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomedical ResearchHematologyHumans

Identifiers

PMID38739717
PMCPMC11279253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.